Nurix Therapeutics Inc. monthly returns
Nurix Therapeutics Inc. has averaged 1.22% per month, positive in 43% of months. Month-by-month returns for Nurix Therapeutics Inc. (NRIX) below, through October 16, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Nurix Therapeutics Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | +3.0% | |
| Sep 2026 | -8.0% | |
| Aug 2026 | +11.1% | |
| Jul 2026 | -4.3% | |
| Jun 2026 | +36.6% | |
| May 2026 | +6.3% | |
| Apr 2026 | +7.7% | |
| Mar 2026 | -2.9% | |
| Feb 2026 | -3.3% | |
| Jan 2026 | -12.9% | |
| Dec 2025 | +7.3% | |
| Nov 2025 | +36.6% | |
| Oct 2025 | +40.0% | |
| Sep 2025 | -1.1% | |
| Aug 2025 | -17.1% | |
| Jul 2025 | -1.1% | |
| Jun 2025 | +7.1% | |
| May 2025 | -7.8% | |
| Apr 2025 | -2.9% | |
| Mar 2025 | -23.1% | |
| Feb 2025 | -21.6% | |
| Jan 2025 | +4.6% | |
| Dec 2024 | -14.8% | |
| Nov 2024 | -10.0% | |
| Oct 2024 | +9.4% | |
| Sep 2024 | -10.8% | |
| Aug 2024 | +15.2% | |
| Jul 2024 | +4.8% | |
| Jun 2024 | +32.5% | |
| May 2024 | +31.0% | |
| Apr 2024 | -18.2% | |
| Mar 2024 | +19.0% | |
| Feb 2024 | +56.3% | |
| Jan 2024 | -23.4% | |
| Dec 2023 | +65.9% | |
| Nov 2023 | +11.3% | |
| Oct 2023 | -28.9% | |
| Sep 2023 | -7.5% | |
| Aug 2023 | -12.5% | |
| Jul 2023 | -2.8% | |
| Jun 2023 | -1.3% | |
| May 2023 | +5.1% | |
| Apr 2023 | +8.4% | |
| Mar 2023 | -5.8% | |
| Feb 2023 | -23.3% | |
| Jan 2023 | +11.9% | |
| Dec 2022 | -11.4% | |
| Nov 2022 | -2.7% | |
| Oct 2022 | -2.3% | |
| Sep 2022 | -17.2% | |
| Aug 2022 | -1.4% | |
| Jul 2022 | +26.0% | |
| Jun 2022 | +25.6% | |
| May 2022 | -8.9% | |
| Apr 2022 | -21.0% | |
| Mar 2022 | -13.4% | |
| Feb 2022 | -13.2% | |
| Jan 2022 | -35.7% | |
| Dec 2021 | +0.5% | |
| Nov 2021 | -13.8% | |
| Oct 2021 | +11.6% | |
| Sep 2021 | -6.9% | |
| Aug 2021 | +4.7% | |
| Jul 2021 | +15.9% | |
| Jun 2021 | -4.9% | |
| May 2021 | -19.9% | |
| Apr 2021 | +12.0% | |
| Mar 2021 | -12.7% | |
| Feb 2021 | -2.1% | |
| Jan 2021 | +10.6% | |
| Dec 2020 | -22.9% | |
| Nov 2020 | +68.5% | |
| Oct 2020 | -27.6% | |
| Sep 2020 | +49.2% | |
| Aug 2020 | +20.7% |
Monthly total return (since Nov 2021)#
Nurix Therapeutics Inc. returns by calendar month#
Every month of every year since 2021, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: +2.99% — 4th of 6 Octobers since 2021 at the last close; the average October returned +6.0%.
| Month | −70%0+70% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | -7.5% | -4.1% | 50% | +11.9% 2023 | -35.7% 2022 | |
| Feb | -1.2% | -8.2% | 17% | +56.3% 2024 | -23.3% 2023 | |
| Mar | -6.5% | -9.3% | 17% | +19.0% 2024 | -23.1% 2025 | |
| Apr | -2.3% | +2.4% | 50% | +12.0% 2021 | -21.0% 2022 | |
| May | +1.0% | -1.4% | 50% | +31.0% 2024 | -19.9% 2021 | |
| Jun | +15.9% | +16.4% | 67% | +36.6% 2026 | -4.9% 2021 | |
| Jul | +6.4% | +1.8% | 50% | +26.0% 2022 | -4.3% 2026 | |
| Aug | +0.0% | +1.6% | 50% | +15.2% 2024 | -17.1% 2025 | |
| Sep | -8.6% | -7.8% | 0% | -1.1% 2025 | -17.2% 2022 | |
| Oct | +6.0% | +9.4% | 60% | +40.0% 2025 | -28.9% 2023 | |
| Nov | +4.3% | -2.7% | 40% | +36.6% 2025 | -13.8% 2021 | |
| Dec | +9.5% | +0.5% | 60% | +65.9% 2023 | -14.8% 2024 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from NRIX's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Nurix Therapeutics Inc.'s average monthly return?
- Nurix Therapeutics Inc. (NRIX) has averaged about 1.22% per month, positive in roughly 43% of months. The best month was Dec 2023 (+65.9%) and the worst was Jan 2022 (-35.7%).